Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21.3Revenue $M17.5Net Margin (%)124Altman Z-Score0.5
Enterprise Value $M9.6EPS $0.5Operating Margin %61.9Piotroski F-Score4
P/E(ttm)1.0Beneish M-Score--Pre-tax Margin (%)61.9Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsN
Price/Sales1.25-y EBITDA Growth Rate %--Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-62.4ROA % (ttm)68.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)90.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M44.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZNCharles Brandes 2015-09-30 Sold Out $0.91 - $1.7
($1.23)
$ 0.48-61%Sold Out0
ENZNCharles Brandes 2015-06-30 Reduce-0.02%$1.06 - $1.72
($1.27)
$ 0.48-62%Reduce -75.12%257,775
ENZNCharles Brandes 2015-03-31 Add$0.95 - $1.23
($1.03)
$ 0.48-53%Add 0.40%1,036,073
ENZNMichael Price 2014-12-31 Sold Out -0.05%$0.89 - $1.21
($1.05)
$ 0.48-54%Sold Out0
ENZNMichael Price 2014-09-30 Reduce-0.05%$1.02 - $1.75
($1.25)
$ 0.48-62%Reduce -54.56%340,000
ENZNGeorge Soros 2014-09-30 Sold Out $1.02 - $1.75
($1.25)
$ 0.48-62%Sold Out0
ENZNGeorge Soros 2014-06-30 Buy $0.81 - $1.18
($0.95)
$ 0.48-49%New holding50,123
ENZNSeth Klarman 2014-03-31 Sold Out -0.14%$0.861 - $1.26
($1.04)
$ 0.48-54%Sold Out0
ENZNSeth Klarman 2013-12-31 Reduce-0.16%$1.15 - $1.74
($1.54)
$ 0.48-69%Reduce -43.60%4,337,858
ENZNCharles Brandes 2013-06-30 Add0.02%$1.6 - $3.95
($2.93)
$ 0.48-84%Add 184.52%1,026,723
ENZNCharles Brandes 2013-03-31 Add0.01%$3.79 - $4.99
($4.54)
$ 0.48-89%Add 432.17%360,865
ENZNFirst Eagle Investment 2012-12-31 Sold Out -0.013%$4.35 - $7
($6)
$ 0.48-92%Sold Out0
ENZNCharles Brandes 2012-12-31 Add$4.35 - $7
($6.03)
$ 0.48-92%Add 35.19%67,810
ENZNFirst Eagle Investment 2012-09-30 Reduce-0.02%$6.42 - $7.17
($6.8)
$ 0.48-93%Reduce -56.42%490,142
ENZNCharles Brandes 2012-06-30 Add$5.87 - $7.06
($6.44)
$ 0.48-93%Add 58.41%51,070
ENZNCharles Brandes 2012-03-31 Buy $6.54 - $7.82
($6.67)
$ 0.48-93%New holding32,240
ENZNCarl Icahn 2011-09-30 Add0.07%$7.24 - $10.37
($8.8)
$ 0.48-95%Add 25.00%5,904,863
ENZNGeorge Soros 2011-06-30 Sold Out $9.97 - $11.81
($10.79)
$ 0.48-96%Sold Out0
ENZNMichael Price 2011-03-31 Add0.16%$10.14 - $12.48
($11.15)
$ 0.48-96%Add 16.65%700,000
ENZNGeorge Soros 2011-03-31 Reduce$10.14 - $12.48
($11.15)
$ 0.48-96%Reduce -52.50%30,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-70.35view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-92.25view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-92.25view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-92.59view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-92.51view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-92.48view
Young Richard ADirector 2012-03-15Sell2,000$6.92-92.63view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-92.37view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-92.78view
LEBUHN ROBERTDirector 2011-06-01Sell8,702$10.57-95.18view

Quarterly/Annual Reports about ENZN:

News about ENZN:

Articles On GuruFocus.com
Top Micro-Cap Picks From the Gurus Jun 23 2015 
Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
GuruFocus Real Time Picks of the Week Jan 10 2014 
Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
First Pacific Advisors’ Top New Buys Aug 08 2012 
Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 
Carl Icahn Buys NAV, CHK, ENZN, AMLN, CMC, Feb 15 2011 
Despite Bearish View, Seth Klarman Holds These Stocks: VSAT, THRX, NWSA, BBEP, ENZN, CSE Nov 25 2010 

More From Other Websites
ENZON PHARMACEUTICALS, INC. Financials Mar 25 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: 2015 By the Numbers Mar 24 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... Mar 21 2016
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Feb 23 2016
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Feb 09 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... Jan 27 2016
Enzon Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 10 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 07 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 03 2015
What Do Hedge Funds Think of Enzon Pharmaceuticals, Inc. (ENZN)? Nov 25 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 12 2015
ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 06 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 15 2015
Guidance & Quarterly Review on Four Biotech Companies Aug 14 2015
ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 07 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 08 2015
Enzon Pharmaceuticals Inc (ENZN)’s Shares Rally After Special Cash Dividend Announcement Jul 06 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jul 02 2015
ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 13 2015
Voltari Corp (VLTC): Carl Icahn Stirring Yet Another Pot Apr 01 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)